A previous study has shown that ASPM was highly expressed in glioma cells, and the abnormal expression of ASPM regulated by transcriptional regulation of FoxM1 contributed to the aggressiveness of gliomas (Zeng et al., 2020). Here, ASPM is linked to central nervous system cancer.